Invitation: Roche Diagnostics Investor Day 2024

  The Roche Investor Relations team would like to invite you to the Roche Diagnostics Investor Day that will take place in London on Wednesday, 22 May 2024, starting at 12:00 BST local time and will finish at 15:30 BST with a reception.The Roche Diagnostics Investor Day will address the following topics:Mass spectrometryContinuous glucose monitoringNext generation sequencingPoint of careUpcoming molecular diagnostics launchesNeurology biomarkers in development Presenters include:Matt Sause, CEO Roche DiagnosticsAlan Hippe, Chief Financial and IT OfficerPalani Kumaresan, Global Head of Roche Diagnostics Solutions (RDS)Benjamin Lilienfeld, Lifecycle Leader Serum Work Area SystemsJochen Berchtold, Franchise Lead Insulin Therapy SolutionsIldiko Amann-Zalan, Head of Research& Development Roche Diagnostics SolutionsNico Michel, Lifecycle Leader Infectious Diseases - Molecular LabOlivier Gillieron, Lifecycle Leader Cardiometabolic and NeurologyMeeting information:Date/Time (BST):Wednesday, 22 May 202412:00 - 13:00 Registration and lunch13:00 - 15:30 Presentations& Q&A15:30 - 16:15 Refreshments with Roche Management TeamVenueConvene (formerly etc venues)133 HoundsditchLondon EC3A 7BX>mapTo register for the event, please follow this  >link (passcode: Dia2024).The slides will be available for download at 12:00 BST on the day of the event.>click here  Alternatively you may participate virtually in the webinar (no access to speakers, pre-registration requi...
Source: Roche Investor Update - Category: Pharmaceuticals Source Type: news